Catherine Coste insider trades

Open-market stock purchases and sales by Catherine Coste, Director at Biolife Solutions Inc, from SEC Form 4 filings since Oct 26, 2020.

Recent trades

DateStockTradeValue
Feb 24, 2026BLFS Biolife Solutions IncBought (not open market)—

Companies traded

  • BLFS Biolife Solutions Inc: other filings, last Feb 24, 2026
  • BMRA Biomerica Inc: 2 buys, last Dec 13, 2024
  • RNLX Renalytix plc: other filings, last Nov 20, 2023
  • UTRS Minerva Surgical Inc: other filings, last Jun 10, 2022
  • BRMA Biomerica Inc: other filings, last Dec 9, 2021

Get free alerts when Catherine Coste files a new trade →